Trade Setup Buy Target $7.55 Sell Target $10.14 Aravive, Inc., a clinical stage biotechnology company, focuses on developing therapies for solid tumors and hematologic malignancies. Its lead candidate is AVB-S6-500, a soluble Fc-fusion protein, which is in Phase 1b/2 clinical trials for the treatment of platinum- resistant recurrent ovarian cancer, as well as for the […]
Read MorePlus, JPMorgan’s Jaime Dimon said the coronavirus crisis will produce a “bad recession,” oil is lower as the OPEC+ meeting to discuss a production cut is delayed, and Apple said it will deliver 1 million face shields per week starting this week.
Read MorePlus, oil is climbing again on reports that OPEC+ is meeting Monday to discuss production cuts, 3M said it is increasing production capacity for its masks for healthcare providers to 50 million per month, and Tesla delivered more vehicles than expected in the first quarter.
Read MorePlus, oil is climbing after Trump said Russia and Saudi Arabia will work toward easing the pressure on oil by ending their price war, U.S. coronavirus cases rose past 216,000, and Luckin Coffee shares plummeted after the company disclosed that its COO had fabricated 2019 sales figures.
Read MoreFor the last few weeks, I believe that one of the biggest reasons investors, and the public at large have been so uncertain is simply because the scope of the spread of COVID-19 infection really is. Shelter-in-place orders in some cities and states followed stay-at-home and self-isolating policies that have taken place pretty much everywhere […]
Read MorePlus, President Trump abandoned his hope of re-opening the U.S. economy by Easter as cases surge to more than 143,000, Macy’s said it is furloughing the majority of its 130,000 employees, and Johnson & Johnson said it will begin human trails on its experimental COVID-19 vaccine by September.
Read MorePlus, the $2 trillion stimulus bill has hit a snag in the House, the U.S. now has the most cases of the coronavirus in the world, and Novartis’ CEO said it’s “too soon” to say if two anti-malaria drugs will be an effective vaccine against the deadly virus.
Read MorePlus, the Senate passed its $2 trillion coronavirus stimulus package, deaths from COVID-19 surpassed 1,000 in the U.S., and Wendy’s withdrew guidance for the year.
Read MorePlus, the market is higher on optimism that a third stimulus bill will be finalized today, Gilead Sciences’ experimental COVID-19 treatment, remdesivir, received Orphan Drug Designation from the FDA, and General Motors said it is conserving cash and drawing down $16 billion from credit lines.
Read MorePlus, the Fed issued new initiatives in an effort to calm the market, the Senate is still negotiating a $2 trillion stimulus package, GE’s aviation unit is laying off 10% of its workforce, and CVS is hiring 50,000 workers.
Read MorePlus, Senate republicans unveiled the third coronavirus relief package, California residents are under lockdown, and JPMorgan and Walmart are giving cash bonuses to front-line employees.
Read MorePlus, the Trump administration is seeking a third coronavirus stimulus package, the WHO warns that the virus can in some cases survive in the air, and Cisco said that there have been 5.5 billion meeting minutes for its Webex video conferencing platform since the start of the month.
Read MorePlus, airlines could be in danger, and Regeneron and Sanofi are soon to begin human trials on a treatment for COVID-19.
Read MorePlus, the global rout for stocks continues, the NBA suspended its season after a player tested positive for the coronavirus, and shares of Carnival cruise line are down sharply after it announced suspending operations for one of its ship fleets.
Read MorePlus, cruise stocks are in free-fall, and Twitter CEO Jack Dorsey get’s to keep his job.
Read More